Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular response to first line nilotinib in a patient with e19a2 BCR-ABL1 chronic myeloid leukemia.

× No keyword cloud information.

5 in total

1. Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.

Authors: Stephen E Langabeer; Sarah L McCarron; Johanna Kelly; Janusz Krawczyk; Suzanne McPherson; Kanthi Perera; Philip T Murphy
Journal: Case Rep Hematol Date: 2012-07-02

2. Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript.

Authors: Marianna Greco; Giovanni Caocci; Giorgio La Nasa
Journal: Case Rep Hematol Date: 2013-07-11

3. Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia.

Authors: Sarah L McCarron; Karena Maher; Johanna Kelly; Mary F Ryan; Stephen E Langabeer
Journal: Case Rep Hematol Date: 2013-09-16

4. Molecular responses in e19a2 BCR-ABL1 chronic myeloid leukemia.

Authors: Laura Kearney; Mireille Crampe; Eibhlin Conneally; Janusz Krawczyk; Senthil Kumar; Philip T Murphy; Vitaliy Mykytiv; Mary-Frances Ryan; Stephen E Langabeer
Journal: Leuk Res Rep Date: 2020-03-12

Review 5. Prognostic Significance of Transcript-Type BCR - ABL1 in Chronic Myeloid Leukemia.

Authors: Matteo Molica; Elisabetta Abruzzese; Massimo Breccia
Journal: Mediterr J Hematol Infect Dis Date: 2020-09-01 Impact factor: 2.576

5 in total